The FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found Problems.
The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...
The Herald Review7h
Is It Spring Yet?
I’m micro-dosing my way through this wintry moment in American history, with the simple act of looking closely for each tiny ...
More than 9,800 women are suing hair relaxer makers over cancer risk claims
Thousands of women claim hair relaxers cause cancer, citing studies linking them to increased risks. Legal battles grow ...
Japanese plant yields compounds that exhibit strong anti-HIV activity
Researchers have discovered that Daphne pseudomezereum (commonly known as Onishibari) contains a substance inhibiting ...
Novartis47m
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...